Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AdaptHealth (AHCO) EBT (2018 - 2025)

AdaptHealth has reported EBT over the past 8 years, most recently at -$98.0 million for Q4 2025.

  • Quarterly results put EBT at -$98.0 million for Q4 2025, down 238.58% from a year ago — trailing twelve months through Dec 2025 was -$15.2 million (down 111.14% YoY), and the annual figure for FY2025 was -$15.2 million, down 111.14%.
  • EBT for Q4 2025 was -$98.0 million at AdaptHealth, down from $36.4 million in the prior quarter.
  • Over the last five years, EBT for AHCO hit a ceiling of $92.4 million in Q2 2021 and a floor of -$487.5 million in Q3 2023.
  • Median EBT over the past 5 years was $23.5 million (2022), compared with a mean of -$15.7 million.
  • Biggest five-year swings in EBT: surged 996.25% in 2022 and later plummeted 8692.22% in 2023.
  • AdaptHealth's EBT stood at $33.5 million in 2021, then crashed by 90.56% to $3.2 million in 2022, then plummeted by 8692.22% to -$271.7 million in 2023, then skyrocketed by 126.03% to $70.7 million in 2024, then plummeted by 238.58% to -$98.0 million in 2025.
  • The last three reported values for EBT were -$98.0 million (Q4 2025), $36.4 million (Q3 2025), and $51.7 million (Q2 2025) per Business Quant data.